Human IFN-γ T cell ELISPOT antibody pair - 10-plate

SKU
CT640-10
Validated ELISPOT antibody pair; reagents available separately (960 determinations).
Format
10-plate
Price
€ 655
Documentation
Data sheet
Manual
SDS
Reactivity
Human
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT antibody pairs are validated for high assay performance using the same reagents and materials included in U-CyTech ELISPOT kits. These antibody pairs are optimized for reliable and reproducible ELISPOT assays.
The antibody pairs are available in convenient 10-plate and 20-plate format, providing 960 or 1920 determinations, respectively.
Compatible reagents for ELISPOT assays can be purchased separately, allowing customization of your ELISPOT workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
3458

References

Authors, et al. Title Journal Year Volume Pages
Maria Zanone Association of cytomegalovirus infections with recurrence of humoral and cellular autoimmunity to islet autoantigens and of type 1 diabetes in a pancreas transplanted patient Transpl Int 2010 23 333-7
Christian Pfleger Association of T-cell reactivity with beta-cell function in recent onset type 1 diabetes patients J Autoimmun 2010 34 127-35
Xia Wu The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy Cancer Immunol Immunother 2010 59 279-91
Kevan Herold Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes Diabetes 2009 58 2588-95
S Candon Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients Am J Transplant 2009 9 2346-54
S Weenink Autoantibodies and associated T-cell responses to determinants within the 831-860 region of the autoantigen IA-2 in Type 1 diabetes J Autoimmun 2009 33 147-54
Wu-ning Mo Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen Chin Med J (Engl) 2009 122 1173-8
Jeroen Gerrits T-cell reactivity during tapering of immunosuppression to low-dose monotherapy prednisolone in HLA-identical living-related renal transplant recipients Transplantation 2009 87 907-14
Jeroen Gerrits Non-HLA T-cell reactivity during the first year after HLA-identical living-related kidney transplantation Clin Transplant 2009 23 740-7
Chantal de Koning Clinimetric evaluation of methods to measure muscle functioning in patients with non-specific neck pain: a systematic review BMC Musculoskelet Disord 2008 9 142